Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Gyre Therapeutics, Inc. Common Stock (GYRE) has a market cap of $715.90M with year-over-year revenue growth of -6.8%. Net margin stands at 16.9%. The stock trades at a P/E ratio of 40.0.
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, GYRE posted revenue growth of -6.8% and trades at a P/E of 40.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.